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R E S E A R C H
Improving Clinical Outcomes and Quality of 
Life with Massage Therapy in Youth and Young 
Adults with Cystic Fibrosis: a Pilot Study
Background: Cystic Fibrosis (CF) is an autosomal 
recessive disorder of exocrine glands characterized 
by abnormal production of thick mucus, primar-
ily in bronchi of the lungs. Individuals experience 
recurrent respiratory infections, increased work of 
breathing, cough and musculoskeletal changes with 
pain. Previous research found that massage therapy 
(MT) decreased pain, muscle tightness, and anxiety 
in individuals with CF, but did not use valid/reliable 
measurements of quality of life (QOL).
Purpose: To evaluate the effects of MT on QOL 
and clinical outcomes in individuals 8 to 21 years 
old with CF. 
Setting: A 622-bed nonprofit pediatric hospital 
in Ohio in the United States.
Participants: Convenience sample of 24 patients 
with CF; 12 randomly assigned to treatment and 
control groups, respectively. 
Research Design and Intervention: Prospective 
two-group controlled pre/post pilot study using 
deep tissue myofascial trigger point massage over 
10 to 12 weeks.
Measurements: Pediatric Quality of Life Inven-
tory (Peds QL 4.0); Cystic Fibrosis Questionnaire-
Revised (CFQ-R); numeric rating scales (NRS) for 
pain, muscle tightness, ease of breathing, relax-
ation; pulmonary function (PFT); single breath 
count; thoracic excursion (TE).
Results: All participants were Caucasian; mean 
age 15.7 (SD = 3.5) years; 16 (66.6%) female. 
No significant differences were found in terms 
of age, gender, baseline pain between MT and 
control groups. At the final visit, compared to the 
control group, the children in MT group showed 
statistically significantly reduced muscle tight-
ness (p = .048) with a large effect size (ω²=0.163) 
and marginally statistically significantly higher 
levels of relaxation (p = .052), less pain (p = .076), 
and improved upper TE (p = .078) and lower TE 
(p = .056) scores with large and moderate effect 
sizes (ω² = 0.156, ω² = 0.095, ω² = 0.083, and ω² 
= 0.073). No statistically significant differences in 
children’s and caregivers’ QOL scores between the 
two groups were found. 
Conclusions: Massage therapy was found to 
significantly reduce muscle tightness, marginally 
significantly help pain, relaxation, and thoracic 
excursion in participants with CF.
KEY WORDS: cystic fibrosis; massage therapy; 
musculoskeletal pain; pulmonary function; quality 
of life
INTRODUCTION
Cystic Fibrosis (CF), a common life-shortening 
genetic disease, affects approximately 30,000 indi-
viduals in the United States. The incidence of CF 
varies by race and ethnicity, with 1:3200 whites, 
1:15000 people of African descent, and 1:35000 
people of Asian descent.(1,2) The disease results 
from mutations in the gene that codes for the cys-
tic fibrosis transmembrane conductance regulator 
(CFTR) leading to abnormal movement of salt and 
water and retention of thick, sticky mucous in the 
lungs, pancreas, and other organs.(3) Consequently, 
most individuals with CF develop chronic bacterial 
lung infections and pancreatic insufficiency with 
malnutrition. Morbidity and mortality are primarily 
due to a progressive decline in lung function and 
eventual respiratory failure. Although there is still no 
cure for CF, medical discoveries are increasing life 
expectancy, with median predicted survival age now 
exceeding 40 years.(1,3) As CF progresses, individuals 
often experience an increase in pulmonary exacerba-
tions and associated respiratory symptoms. Increased 
respiratory effort and inefficient muscle function and 
fatigue may result in musculoskeletal changes and 
associated pain, affecting posture, ease of breathing, 
comfort, and overall quality of life (QOL).
Anecdotally, over several years of practice at the 
study site, prior to and including time of the study, 
licensed massage therapists providing massage therapy 
(MT) to hospitalized youth and young adults with 
CF found recurrent patterns of muscle dysfunction 
and postural changes, suggesting overuse of respira-
tory muscles and inefficient recruitment of accessory 
Kathleen (Kate) Zink, MSN, RN, AHN-BC, LMT,1* [retired], Barbara Chini, MD,2 Joyce 
Cowens, AD, LMT,4 Lois Kremer, BSN, RN,1 [retired], Li Lin, MS, BS3
1Division of Child Life & Integrative Care, 2Division of Pulmonary Medicine, 3Patient Services, Research, Cincinnati 
Children’s Hospital Medical Center, Cincinnati, OH; 4All About Health, Cincinnati, OH, USA
5
International Journal of Therapeutic Massage and Bodywork—Volume 12, Number 1, March 2019
METHODS
Participants
Participants were 8- to 21-year-old English speak-
ing males and females with a CF diagnosis based 
upon documented positive sweat test (> 60 mEq/
ml by quantitative pilocarpine iontophoresis) and 
genotype with two identified mutations consistent 
with CF who received approval to participate from 
a pulmonary physician, gave informed consent if 
adult participant, or consent obtained from primary 
caregiver if participant younger than 18 years old, 
and agreed to refrain from receiving MT outside of 
study activities for the duration of study participa-
tion. Data collection occurred from September 2013 
through March 2015. Recruitment activities included 
medical record review for eligibility of patients with 
CF followed by invitation to participate during clinic 
appointment (convenience sample). 
Potential study participants were excluded if an ill-
ness was present at the time of enrollment for which 
MT was contraindicated, per pulmonary physician; if 
the person was unable to lay flat on the massage table; 
had a skin condition or injury contraindicated for MT; 
or had a history of lung and/or liver transplant.
Confidentiality was maintained by assigning 
a unique number to each participant. There were 
12 participants in treatment and control groups, 
respectively; all were enrolled from the CF clinic 
database at a Midwestern-pediatric-hospital in the 
United States. 
Participants in the treatment group received a series 
of three to five MT treatments over 10 to 12 weeks. 
Each treatment lasted 60–90 min. If diagnosed with 
a pulmonary exacerbation requiring hospitalization, 
treatment participants were permitted to continue in 
the study with pulmonary physician approval. Par-
ticipants with a history of hepatomegaly or spleno-
megaly were eligible for the study with the provision 
that abdominal massage was not performed. If the 
participant had recently received MT, the first study 
visit was delayed for 30 days. 
For all treatment participants, time between visits 
was incrementally increased, following a common 
outpatient model for massage therapy. Anecdotally, 
as a client’s symptoms improve following repeated 
sessions, time between visits is often increased. For 
this study, time between visits increased incremen-
tally from 1 week, to 2 weeks, to 3 weeks, to 4 weeks. 
This study compared findings over time, looking for 
patterns in timing of musculoskeletal changes follow-
ing MT and how long the changes lasted. 
Participants in the control group were seen twice in 
the outpatient clinic for data collection at study Weeks 
zero (time one) and 10 (final study visit). Follow-up 
phone calls correlated with treatment group visits at 
Weeks One, Three, and Six. The control group did not 
receive MT during active study participation. 
muscles. With overuse, muscle fatigue can occur, with 
the development of trigger points (TrP). Trigger points, 
highly sensitive tender nodules in tight, overused, or 
strained muscles, may restrict mobility as the muscle 
itself is restricted from lengthening upon demand.(4) 
Subsequently, muscle fatigue develops as muscles 
work beyond normal capacity. When muscle fatigue 
combines with tissue restriction, circulation through 
muscles is impaired, limiting the amount of oxygen 
and nutrients traveling to the muscles and waste 
products leaving the muscles. Toxicity within muscle 
tissue irritates nerve endings, and can contribute to 
muscle weakness and associated pain.(4,5) In summary, 
hospitalized patients with CF experiencing disease 
progression often presented with muscle dysfunction 
and pain—factors negatively influencing QOL.
Previous studies of individuals with CF found 
difficulty breathing, muscle tightness, and postural 
changes associated with pain. Even children with 
mild CF reported frequent mild pain, especially in 
chest, head/neck, and abdomen.(6) In youth, health-
related QOL was found to significantly decrease as 
pain increased or persisted over time.(7) A database 
review from this pediatric study hospital in the state 
of Ohio in the United States found that MT and MT, 
combined with another modality such as energy 
therapy, significantly decreased pain in hospitalized 
youth with CF.(8) Studies of adults with CF found that 
MT decreased muscle tightness and musculosketeletal 
pain in postural muscles.(9.10) Studies of parents ad-
ministering nighttime massage found lower anxiety 
and improved pulmonary function in children with 
asthma,(11) and decreased anxiety in children with CF 
and their parents, along with improved child mood 
and peak airflow.(12) Massage protocols in previous 
studies in CF varied in number of sessions, from 
single dose(9,10) to nightly for 30 consecutive days.(12) 
In summary, there were no studies on massage and 
CF which directly measured QOL. However, there 
was preliminary support for the use of MT to promote 
comfort and relaxation and improve ease of breathing 
in children and young adults with CF. 
The purpose of this pilot study was to describe 
the effects of deep-tissue MT using myofascial TrP 
techniques on QOL in youth and young adults 8 to 
21 years old with CF. The study proposed that a mas-
sage protocol focusing on releasing tight tissue and 
TrPs, improving tissue mobility and functioning, and 
decreasing musculoskeletal pain, may improve QOL 
in individuals with CF. (See Appendix A: Protocol). 
The primary aim of this study was to evaluate if 
MT in youth and young adults with CF resulted in 
improved QOL when compared to youth and young 
adults with CF who did not receive MT. Quality of 
life was measured with standardized QOL tools and 
subjective measures including ease of breathing, 
muscle tightness, and overall relaxation. Results of 
this study found preliminary support for the use of MT 
in improving QOL in youth and young adults with CF.
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version is a 35-item tool with eight domains: physical, 
emotional state, social, body image, eating, treatment 
burden, respiratory, and digestion. Each scale yields a 
standardized score ranging from 0–100, with higher 
scores indicating better HRQOL.(18) The Adolescent/
adult version demonstrates internal consistency (α = 
0.67–0.94) and test/retest reliability (rs = 0.45–0.90) 
among patients with CF ages 14 to 53 years old.(19) 
The child version demonstrates internal consistency 
and reliability (α = 0.7–0.92) among children with CF 
ages 6 to 13 years old.(20) Construct validity has been 
tested by means of correlation with FEV1 % predicted 
(r = 0.01-0.18). The parent version demonstrates in-
ternal consistency (α = 0.59–0.91) and parent/child 
agreement = 0.27–0.57.(20) This study focused on the 
child and teen reports.
Subjective Measures of Quality of Life 
In this study, the author created three numeric rat-
ing (0–10) scales capturing subjective descriptions 
of QOL in individuals with CF: 
1. Muscle tightness. Participants were asked: “On 
a scale from 0 to 10, how would you describe 
how your muscles feel right now, with 0 being 
the least tight (you are able to move very easily), 
and 10 being the most tight, the greatest amount 
of tightness and greatest difficulty moving you 
have ever experienced?”
2. Ease of breathing. Participants were asked: “On 
a scale from 0 to 10, how would you describe 
your breathing right now, with 0 being the least 
difficulty breathing (you are able to breathe very 
easily), and 10 being the most difficulty breathing 
you have ever experienced?”
3. Relaxation. Participants were asked: “On a scale 
from 0 to 10, how would you describe your over-
all relaxation right now, with 0 being the least 
tense and stressed (you feel the most relaxed and 
calm you have ever felt), and 10 being the most 
tense and stressed you have ever felt?”
Pain
In this study, pain was measured using a previously 
established scale, the Numeric Rating Scale (NRS-
11), which is a self-report measure of pain intensity 
for children 8 years and older, with endpoints corre-
sponding to no pain (0) and the worst pain possible 
(10). The pain scores are categorized as mild (1–3), 
moderate (4–6), and severe (7–10). Previously, valid-
ity was demonstrated with three samples of children: 
correlation with the Faces Pain Scale – Revised (r = 
0.87); a visual analogue scale (VAS) (r = 0.89); and 
between-group comparisons of the distribution of 
pain intensity scores on the NRS-11 and VAS which 
showed very similar distributions (paired t = 1.88, df 
= 117, p = .06), except for scores at the very lowest 
Participation in the study was voluntary; par-
ticipants could withdraw at any time. The study in-
cluded financial compensation for study participants 
(maximum $60 control group; $90 treatment group). 
At the conclusion of the study, small bolsters used 
during MT were to be given to the treatment group 
participants. A courtesy massage was to be offered 
to the control group participants at completion of 
data collection. 
Measures
Data were collected by trained study assistants 
during and between visits. Massage therapists were 
trained in, and assisted with, data collection outside 
of the treatment visit.
Statistical Methodology
Descriptive analyses were performed on sample 
demographics and outcome variables in the treatment 
and control groups. Two-sample t test and Fisher’s 
exact test were applied for demographic comparison. 
Continuous variables were summarized using means, 
standard deviations, and ranges, while categorical 
variables were described using counts and percentages. 
Final outcome measures between the treatment and 
control groups were compared by ANCOVA control-
ling for age, gender, and baseline prescores. Effect size 
Omega-squared (ω²) and Cohen’s d were calculated 
to estimate magnitude of the effect. According to 
Cohen,(13) 0.14, 0.06 and 0.01 are the cut points for ω² 
and 0.8, 0.5 and 0.2 for d in terms of large, moderate, 
and small effects. Data were analyzed employing SAS 
statistical software, version 9.3 (SAS Institute, Cary, 
NC). A two-sided significance level was set at 0.05.
Quality of Life Measurements
PedsQL
The PedsQL, originally developed to measure 
health related QOL in children ages 2 to 18 years 
old,(14) was modified to the PedsQL 4.0, a 23-item 
scale of general health-related quality of life (HRQOL) 
in children and adolescents and young adults.(15) The 
PedsQL 4.0 has demonstrated internal consistency 
reliability for the total scale score (child self-report 
α = 0.88, parent proxy report α = 0.90), psychosocial 
scale score (child self-report α = 0.83, parent proxy 
report α = 0.86), and physical health summary scale 
score (child self-report α = 0.80, parent proxy report 
α = 0.88). Construct validity was demonstrated using 
known groups method.(16) This study used the self-
report scales and parent proxy reports for children and 
teens, and self-reports for young adults. 
CFQ-R
The CFQ-R is a disease-specific measure of QOL 
among children and adults with CF.(17) The child 
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Massage techniques were provided by a licensed mas-
sage therapist (LMT) and focused on releasing TrPs 
by applying pressure to affected tissue for 60–90 sec, 
followed by stretching techniques, specifically PIMR 
(post-isometric muscle release), to retrain the affected 
muscle to stay lengthened to its natural resting state. 
The massage focused primarily on muscles involved 
in supporting respiration and posture, areas commonly 
compromised in individuals with CF. Each treatment 
group participant was assigned to a specific LMT. 
When the LMT was unavailable, another study trained 
LMT provided the massage. 
The massage therapy protocol included applica-
tion of massage strokes with the participant placed 
in three different positions on a massage table: 
supine, side-lying and sitting. The sequence of mas-
sage techniques were administered over 60–90 min 
and included:
1. In the supine position, gentle bilateral leg stretch 
and TrP release of quadratus plantae; sacro-sternal 
fascial releases; L5-S1 release; upper trunk and 
bilateral shoulder warm-up; chest warm-up; digi-
tal kneading bilateral temporalis muscles; pos-
terior neck and suboccipital massage; trapezius 
warm-up and release; serratus anterior release; 
pectoralis major TrP release; rectus abdominis 
and psoas TrP release; tensor fascia lata stretch 
and PIMR; and ended with assistive inspiration.
2. In the side-lying position (left side down, then 
repeated all techniques with right side down), 
spine warm-up with fascial stretches; erector 
spinae rocking; intercostal stretch and TrP release; 
levator scapula TrP release and PIMR; rhomboid 
TrP release and PIMR; and ended with pectoralis 
minor TrP release and PIMR.
3. In the sitting position on side of table, thoracic 
PIMR for external intercostals; rotational trunk 
PIMR for intervertebral muscles.
The entire protocol ended with resting hands on 
shoulders followed by relaxation stroking down back. 
Training
Three LMTs assisted the Principal Investigator 
(PI) in study related activities. Two of the LMTs had 
pediatric hospital experience in caring for hospitalized 
youth and young adults with CF. The third LMT had 
extensive experience in myofascial TrP therapy and 
assisted in development of the study MT protocol. 
The LMTs were trained in the MT protocol over three 
practice sessions by the PI and the LMT who assisted 
in protocol development. Additionally, the PI had 
extensive experience in providing massage therapy 
to hospitalized individuals with CF at the study hos-
pital. All LMTs, including the PI, demonstrated the 
ability to consistently provide the massage protocol 
as outlined for the study with replicable skills. 
end of the scales (p = .03 at 0).(21) In this study, the 
NRS scale was administered at predetermined times 
to evaluate potential effects of MT on musculoskel-
etal pain. 
Pulmonary Function
Spirometry
Measurements for this study included the Forced 
Vital Capacity (FVC) and Forced Expiratory Vol-
ume in 1 sec (FEV1), performed using the American 
Thoracic Society standards.(22) Previous studies used 
pulmonary function measurements in individuals with 
CF who received MT.(9,10,12) Forced Vital Capacity 
is the total amount of air forcefully exhaled after a 
full inspiration. During spirometry, the subject must 
inhale as much air as possible and then exhale as much 
air as possible. The “F” in FVC is used because this 
is a forced maneuver. FEV1 is the total amount of 
air forcefully exhaled in the first second following a 
full inspiration. 
Ease of breathing (measured by Single Breath 
Counting Score)
Assessment of the ease of breathing for this study 
was measured using the Single Breath Counting 
Score.(23) This score was determined by having the 
subject stand with arms relaxed at their sides, take 
a large breath and then count out loud, reading the 
numbers from a digital stop watch aloud, one num-
ber per second. The highest number the subject was 
able to verbalize before taking the next breath was 
the score. The Single Breath Counting Score was 
previously found to demonstrate test/retest reliability 
at rest (ICC = 0.93), and construct validity through 
correlations with FEV1 after exercise (r = 0.68, p < 
.001), not at rest.
Thoracic excursion
The upper and lower thoracic excursion of each 
subject was measured by the cloth tape measure 
technique of the subject’s chest.(24) Both upper and 
lower thoracic excursion (thoracic circumference) 
were determined by the following formula: forced 
inspiration minus forced expiration = thoracic excur-
sion. Test/retest reliability was previously determined 
with upper thoracic excursion ICC = 0.91 and 0.86 
(95% CI, 0.69–0.99) for two sessions of measure-
ment, respectively. Lower thoracic excursion ICC of 
0.84 and 0.81 (95% CI 0.69–0.99) was obtained at 
two measurement sessions respectively.
Procedures
Intervention
A specific MT protocol based on deep tissue myofas-
cial TrP therapy(25) was developed by the lead author in 
collaboration with MT experts. The massage protocol 
blended Swedish strokes and myofascial TrP therapy, 
creating a full body sequence of massage strokes. 
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Mean (SD) = 82.22 (16.43)), physical ((Mean (SD) 
= 85.94 (18.63) vs. Mean (SD) 83.59 (16.86)), and 
total health scores ((Mean (SD) = 85.14 (15.66) vs. 
Mean (SD) = 82.70 (15.73)) with Cohen d of 0.21, 
0.08, and 0.25. When compared to the control group, 
by the end of the study, the child psychosocial and 
total health subscales in the treatment group improved 
a little more with very small effect sizes (ω² = 0.006, 
and 0.005) (see Table 1). Additionally, the post parent/
caregiver physical health scores improved more in the 
treatment group than the control group (ω² = 0.010). 
The treatment group reported a decrease in muscle 
tightness ((Mean (SD) = 0.36 (1.81) vs. Mean (SD) 
= 1.80 (1.48), d = 1.06)); greater ease of breathing 
((Mean (SD) = 0.73 (1.01) vs. Mean (SD) = 0.50 
(0.97), d = 0.06)); and improved relaxation ((Mean 
(SD) = 0.91 (1.14) vs. Mean (SD) = 1.40 (1.35), d 
= 0.66)) at the last follow-up call. Compared to the 
control group, muscle tightness in the MT group was 
significantly reduced (p = .048) at post-visit 5, with 
a large effect size (ω² = 0.163). Relaxation scores in 
the MT group were improved (p = .052) compared 
to the control group at post-visit 5, with a large (ω² 
= 0.156) effect size (see Table 2). However, results 
were not statistically significant. Of note, the male 
participants had significantly higher PedsQL scores 
on emotional, social, and school functioning, and gen-
eral psychosocial health than the female participants 
at the conclusion of the study. Interestingly, when 
comparing a child one year younger in age (e.g., 
10-year-old compared to 11-year-old), the younger 
participant had significantly higher social functioning 
scores at the end of the study (p = .0466). 
Timeline
In an effort to determine the body’s ability to main-
tain musculoskeletal changes following the massage 
protocol, time between treatments was gradually 
increased. The required three to five MT treatments 
were administered over 10 to 12 weeks. (See Ap-
pendix B: Timeline).
RESULTS
Demographics
This pilot study enrolled a convenience sample of 
30 males and females, 8- to 21-year-olds; 24 partici-
pants completed the study and six were lost to attrition 
(four declined participation after initial enrollment; 
one was unable to be reached; and one was withdrawn 
due to missed visits (only completed two of the three 
required visits). All remaining participants completed 
the required number of visits/phone data collection. 
All participants in the study were Caucasian, rang-
ing in age from 9.9 to 20.6 years old, with a mean 
age of 15.7 (SD = 3.5) years. Sixteen (66.6%) of the 
participants were female. There were no significant 
differences for age and gender (p > .66) between the 
treatment and control groups. The number of hospi-
talizations was compared between the treatment and 
control groups. Three participants in the treatment 
group were hospitalized four times collectively and 
six participants in the control group were hospitalized 
16 times collectively, (ranging from 1 to 8 times). The 
number of hospitalizations in treatment group was 
lower (Mean (SD) = 0.33 (0.65) than control group 
(Mean (SD) = 1.35 (2.30), but did not achieve statisti-
cal significance (Wilcoxon rank-sum test, Z = 1.2741, 
p = .2026) with close to medium effect size (r = 0.24). 
Quality of Life
Quality of life was measured with the PedsQL 4.0 
and CFQ-R and with subjective measures of muscle 
tightness, ease of breathing, and relaxation created 
for this study. Previous studies described similar 
quality of life indicators for individuals with CF (e.g., 
subjective reports of improved breathing;(9,10,12) de-
creased pain, less restricted breathing, and increased 
relaxation(21)); and reduced muscle tightness, easier 
breathing, increased muscle strength and chest expan-
sion, improved sleep, increased relaxation, and an 
overall feeling of improved well-being.(10) 
No statistically significant differences in children’s 
and caregivers’ QOL scores in treatment group be-
tween pre- and post-MT intervention or compared 
to the control group was achieved when using the 
PedsQL 4.0 and the CFQ-R tools. However, PedsQL 
4.0 scores clinically improved in the treatment group 
in psychosocial ((Mean (SD) = 84.72 (15.04) vs. 
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Table 1. Children and parent post-intervention Peds QL 4.0 score
LSmean for Post Score
p-value Control Treatment
Children
Total Scale 0.968 82.56 82.91
Physical Health 0.927 82.87 82.85
Emotional Functioning 0.113 84.05 81.59
Social Functioning 0.259 89.46 92.26
School Functioning 0.613 73.70 76.15
Psychosocial Health 0.936 82.40 83.19
Parent
Total Scale 0.724 72.51 70.70
Physical Health 0.935 75.70 76.41
Emotional Functioning 0.863 70.99 69.58
Social Functioning 0.635 77.34 74.34
School Functioning 0.725 65.34 62.24
Psychosocial Health 0.680 71.00 68.44
LSmean: Least-Squares mean adjusted for the covariates age, 
gender, and pre-score
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to 9-year-old) (p = .0418) had significantly higher 
FVC percent predicted measure by 1.13 at the end 
of the study (see Table 3). The treatment group had 
higher single breath counting scores (d = 0.47) than 
the control group at the last study visit. No statisti-
cally significant changes in PFTs were found for either 
group over time.
DISCUSSION
Cystic Fibrosis is a common, life-shortening 
genetic disease which may negatively affect QOL. 
With disease progression, individuals may experience 
an increase in pulmonary exacerbations including 
increased work of breathing and related cough, and 
musculoskeletal changes with pain and tissue dys-
function. Children with mild CF have reported fre-
quent mild pain in chest, head/neck, and abdomen.(6) 
Previously, youth with CF were found to experience 
significant decreases in QOL as pain increased or 
persisted over time.(7) 
Additional findings supported the use of massage 
therapy in individuals with CF to improve QOL—for 
example, MT significantly decreased pain in hospital-
ized youth,(8) decreased anxiety and improved mood 
and peak airflow in children,(12) and decreased muscle 
tightness and musculoskeletal pain in postural mus-
cles in adults with CF.(9,10) Other subjective descrip-
tions of improved QOL included improved breathing 
and pulmonary function,(8,9,10) decreased pain, less 
restricted breathing, and increased relaxation,(26) and 
Musculoskeletal Pain
When comparing the participants’ pain scores 
of mild, moderate, and severe, the treatment group 
reported lower Pain NRS score ((Mean (SD) = 0 
(0) vs. Mean (SD) = 0.67 (1.23), d = 0.94)) at the 
last follow-up call. NRS pain scores had improved 
compared to the control group at post-visit 5, with 
marginal significance (p = .076) and a moderate effect 
size (ω² = 0.095) (see Tables 2 and 3).
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Table 3. Postintervention Clinical Measurements
LSmean for Post Score
p-value Control Treatment Effect 
Size, ω²
Pain NRS score 0.076# 1.44 0.02 0.095
NRS score Muscle Tightness 0.048* 1.48 0.36 0.163
Ease of Breathing 0.223 1.10 0.35 0.032
Ease of Relaxation 0.052# 1.97 0.66 0.156
Pulmonary Measures Single 
Breath Count  
0.164 17.49 21.27 0.027
Pulmonary Measures Upper 
Mean TE
0.078# 2.94 3.81 0.083
Pulmonary Measures Lower 
Mean TE
0.056# 4.04 5.28 0.073
FVC measured 0.848 3.42 3.44 0.001
FVC percentage 0.864 92.94 93.58 0.009
FEV1 measured 0.968 2.73 2.73 0.002
FEV1 percentage 0.871 84.89 85.40 0.005
*p< 0.05; # 0.05≤ p <0.1; 0.14, 0.06 and 0.01 are the ω² cut points 
for large, moderate and small effects;
LSmean: Least-Squares mean adjusted for the covariates age, 
gender, and pre-score
Table 2 Clinical outcome means and standard deviations, not 
adjusted for covariates
Outcome
Treatment Control
Pre_visit 
1
Post_visit 
5
Pre_visit 
1
Post_visit 
5
Pain NRS score
0.67 
(1.23)
0 (0)
1.17 
(1.80)
1.58 
(2.39)
NRS score Muscle 
Tightness  
1.80 
(1.48)
0.27 
(0.65)
2.11 
(1.96)
1.80 
(1.81)
Ease of Breathing  
0.50 
(0.97)
0.36 
(0.67)
0.56 
(0.86)
1.00 
(1.63)
Ease of Relaxation  
1.40 
(1.35)
0.36 
(0.50)
2.28 
(2.05)
2.40 
(2.17)
Pulmonary Measures 
Single Breath Count  
17.00 
(5.01)
20.42 
(9.10)
17.45 
(8.70)
16.73 
(7.10)
Pulmonary Measures 
Upper Mean TE
3.06 
(1.28)
3.72 
(1.23)
3.34 
(1.22)
2.99 
(1.15)
Pulmonary Measures 
Lower Mean TE
5.14 
(2.30)
5.47 
(1.75)
3.90 
(1.56)
3.94 
(1.68)
FVC measured 
3.11 
(1.16)
3.12 
(1.29)
3.73 
(1.33)
3.74 
(1.31)
FVC percentage 
88.17 
(17.07)
88.42 
(17.06)
98.08 
(15.62)
98.08 
(19.13)
FEV1 measured 
2.48 
(0.98)
2.44 
(1.03)
3.13 
(1.13)
3.06 
(1.09)
FEV1 percentage 
81.92 
(20.64)
79.25 
(20.31)
95.08 
(17.09)
92.83 
(21.63)
Pulmonary Function
Pulmonary function measures included upper and 
lower thoracic excursion and spirometry scores (FEV1 
and FVC). The upper and lower Mean TE scores in the 
MT group were improved at the post-visit 5 ((Mean 
(SD) = 3.72 (1.23) vs. Mean (SD) = 3.06 (1.28), d = 
0.53)) and ((Mean (SD) = 5.47 (1.75) vs. Mean (SD) 
= 5.14 (2.30), d = 0.26)). Compared to the control 
group, the upper and lower Mean TE scores were 
marginally statistically significantly higher (p = .078, 
and p = .056) in the last visit, with moderate effect 
sizes (ω² = 0.083 and ω² = 0.073) (see Table 2). The 
PFT in the treatment group showed a slightly higher 
trend than in the control group. The participant who 
was 1 year older in age (e.g., 10-year-old compared 
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visits (e.g., every three months) than a longer, more 
frequent MT intervention. Preventative measures in 
CF care, including MT, may subsequently be found to 
improve musculoskeletal function and form, decrease 
related pain (e.g., triggered by cough and increased 
respiratory effort), and may ultimately contribute to 
a decrease in frequency of hospitalizations and an 
increase in quality of life in individuals with CF. 
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With fingertips bilateral to cervical muscles, 
apply gentle medial pressure alternating left 
to right from upper to lower cervicals (x3).
8. Trapezius warm up and release. Cradle oc-
ciput with left hand while applying pressure 
with right thumb to mid sagittal suture on 
top of head x 1-2 minutes. Sift trapezius 
for areas of restriction and release 1-2 
TrP’s as available. Sift scalenes and release 
Trp’s as indicated. Lift and cradle head on 
open palms, head in forward flexion, x 1-2 
minutes. Follow with occipital base release 
(head on table). Right hand on left shoulder 
and left hand cradling head on left, gently 
resist lateral head flexion left while gently 
resisting left shoulder shrug up and perform 
PIMR x 1. Left hand on right shoulder and 
right hand cradling head on right, gently 
resist lateral head flexion right while gen-
tly resisting right shoulder shrug up and 
perform PIMR x 1. With therapist’s arms 
crossed and under subject’s head, subject’s 
eyes open, move head up to barrier. Instruct 
subject to push back into therapist’s arms, 
breathe in, and then relax head and allow 
therapist to move head farther into flexion. 
Invite subject to drop shoulders down to 
enhance the stretch.
9. a.  Serratus anterior. (Bolster under head). 
Right side. Locate TrP at T6 on lateral 
rib. Instruct subject to breathe in while 
therapist holds TrP with finger tips, raising 
subject’s hand above head and lowering 
flexed arm to side. Repeat sequence as 
indicated. Finish with PIMR x 1.
 b.  Pectoralis major. Bolster under right 
elbow, arm flexed 90 degrees with palm 
on table. Sift lateral body of pectoralis 
major, searching for 2-3 trigger points and 
release if found. Perform pectoralis major 
stretches with subject close to side/edge 
of table. Stretch at 90 degrees abduction 
(palm up), opposite hand fixed on the ster-
nal head (between breast tissue) followed 
by PIMR x 3. 
 Repeat above sequence (serratus anterior and 
pectoralis major) on left side. 
10. Rectus abdominis and psoas (omit this section 
for persons with hepatomegaly or spleno-
megaly). Starting on left side, flex knees, feet 
flat on table. With finger tips, follow inferior 
costal border medial to lateral, for 2 inches, 
searching for TrP’s; hold 60 seconds. Allow 
left flexed knee to drop laterally, externally 
rotating hip. Search anterior ileum for TrP’s 
and release, including ASIS joint. Right leg 
on table, flex left leg 90 degrees off table. 
Gently press fingertips into abdomen 1-2” 
lateral to umbilicus while subject lifts flexed 
APPENDICES
Appendix A: Massage therapy intervention: Myo-
fascial trigger point therapy.
The techniques and sequence detailed below 
were performed at each study visit. Techniques in-
cluded variability in strokes, amount of pressure and 
frequency, e.g., repeated 3-5 times, per therapist’s 
professional judgment, to achieve muscle release. 
Flaxseed pillows and standard pillows or half round 
bolsters were used for proper positioning.
A. Supine position. Bolsters at occiput and under knees.
1. Gentle leg stretch followed by TrP (trigger 
point) release of quadratus plantae at soles 
of feet and Post Isometric Muscle Release 
(PIMR) each leg.
2. Sacro-sternal fascial releases. Hold sacrum in 
palm of hand and allow tissue to relax. Apply 
gentle pressure with other hand on abdomen, 
lower ribcage, and upper ribcage/sternum and 
traction toward umbilicus.
3. L5-S1 release. Stand on right side, place open 
palm right hand under sacrum and open fisted 
left hand horizontal at L5, cupping spinous 
processes. Gently distract hands away from 
one another.
4. Upper trunk/shoulder warm up, right and left 
sides. (Bolster under shoulder being worked) 
Passive arm stretches repeated 5-10 times in 
three arm positions:
i. Upper arm at 90 degrees, elbow flexed, 
palm down. Hand raised toward head, 
then down to side.
ii. Upper arm at 90 degrees, elbow flexed, 
palm down. Elbow raised toward head 
and back down to 90 degree flexion.
iii. Upper arm at 90 degrees, palm facing up. 
Arm raised over head, fingers extended. 
Return arm to 90 degrees flexion.
iv. Remove bolster, reposition under left 
arm/shoulder and repeat sequence on left 
side. Remove bolster.
5. Chest warm up. Digital kneading bilater-
ally, sterno-costal points of attachment, from 
clavicle to xiphoid process (x3). Apply gentle 
pressure to points of attachment bilaterally 
and perform horizontal tissue glide (x3). 
Perform costal raking upper chest bilaterally, 
medial to lateral (5-10 times).
6. Temporalis. (Remove bolster from under 
head). Gentle digital kneading bilateral tem-
poralis muscles 15-30 seconds.
7. Posterior neck and sub occipitals. Cradle head 
with fingertips on posterior cervical muscles. 
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leg and therapist locates psoas muscle. Apply 
light to moderate pressure, allowing psoas to 
soften (30-60 seconds). Release pressure.
 Perform PIMR flexed leg x 1.
 Repeat rectus abdominis and psoas releases 
on right side.
11. Tensor fascia lata (TFL). Therapist on right 
side. Left leg extended, right leg flexed, 
foot crossed left knee and foot flat on table. 
With left hand, gently push right knee to 
left while pulling left ankle with right hand 
across midline. Instruct subject to pull left 
leg lateral (to the left) and push right knee 
into therapist’s hand (to the right) to perform 
PIMR x 3; end last PIMR with medial pull/
jerk. Repeat on left side, changing direction 
of PIMR stretches accordingly. Remove 
bolster from head.
12. Assistive inspiration. Small bolster under 
lower back. Therapist positioned at head of 
table with subject raising arms up with palms 
toward ceiling. Therapist grasps hands, palm 
to palm, interlocking thumbs and bringing 
arms superior, overhead with subject inhaling, 
to expand chest. Subject instructed to exhale 
while therapist brings arms down toward ab-
domen and therapist applies gentle downward 
pressure on inferior ribcage; perform X 3.
B. Side lying position, left side down. Small bolster 
under waist to arch spine laterally; large bolster 
anterior to chest for arm support and between legs/
knees for leg support; pillow bolster under head. 
1. Spine warm up. Standing posterior to sub-
ject, perform passive touch and gentle back 
stretch; one hand on sacrum, other hand on 
upper back, stretching fasciae, hands away 
from one another.
2. Erector spinae. Apply thumb presses with 
rocking motion along spine (deep paraspi-
nals), from upper neck to sacrum, on the up 
side of vertebrae, X 3.
3. Intercostals. Apply gentle stretch, one palm 
down and other palm on top of hand. Gently 
press fascia inward and anterior, over ribs. 
Upper arm above head, subject’s hand hold-
ing head of massage table. Using P-ball or 
fingertips, apply gentle intercostal presses 
from T4 (under axilla) to T12, posterior to 
anterior. Treat costal angle going anterior, and 
then treat anterior intercostals under breast.
4. Levator scapula. Perform digital kneading of 
levator scapulae with upper arm over head. 
With fingertips, locate TrP’s at insertion of 
levator scapulae at superior border and medial 
angle scapula. Treat TrP with massage tool 
at angle of neck where muscle surfaces, at 
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muscle twist at anterior border of trapezius 
and superior medial angle of scapula.
5. Rhomboids. Position upper arm anterior to 
subject, closed fist on massage table and 
elbow flexed and pointed toward ceiling. 
Search rhomboids inferior to superior (cross 
fiber) and treat myofascial trigger points 
along vertebral border of scapula. Move up-
per arm in extension above head and back 
to 90 degree flexion. Finish with PIMR 
rhomboids x 1 by extending arm over head 
(pushing anterior at shoulder).
6. Pectoralis Minor. With upper arm relaxed 
across body and lying on large bolster, palm 
down, perform myofascial TrP therapy. Work 
with fingertips/thumb deep to lateral body of 
pectoralis major from attachments on 5th, 4th, 
and 3rd ribs toward coracoid process. Perform 
PIMR x 1. Assist subject in positioning to the 
right side; repeat above steps 2-6.
C. Sitting position. Therapist assists subject to sitting 
position on side of the table.
1. Thoracic PIMR for external intercostals. 
Therapist in front of subject, subject takes 
breath in while therapist gently assists sub-
ject in performing a side-bending movement 
right, at which time subject releases the breath 
and therapist extends the stretch with gentle 
pressure on right shoulder. Perform PIMR X 
1. Therapist returns subject to center position 
and repeats sequence left.
2. Rotational trunk PIMR for intervertebral 
muscles. Therapist behind subject, instructs 
subject to cross arms at chest, hands on op-
posite shoulders. 
 First position – therapist rotates subject to left 
(grasping right elbow), while subject turns 
head right. Therapist instructs subject to take 
breath in x 5 seconds and release the breath 
out while therapist continues to gently rotate 
trunk left with head turning left. Therapist 
supports back with opposite hand.
 Second position – therapist rotates subject 
to right (grasping left elbow), while subject 
turns head left. Therapist instructs subject 
to take breath in x 5 seconds and release the 
breath out while therapist continues to gently 
rotate trunk right with head turning right. 
Therapist supports back with opposite hand. 
3. Resting hands on shoulders. Therapist 
gently rests hands on subject’s shoulders x 
15-30 seconds.
4. Relaxation stroking. To finish treatment, 
therapist uses full open hands palms down to 
stroke subject from the top of the head, down 
the full back. Perform X 3.
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Appendix B: Timeline for Treatment and Control Group
Treatment group visit schedule
Visit number: 1 2 3 4 5
Study Week: 0 1 3 6 10
Procedures:     
Massage Therapy X X X X X
Measures: 
Peds QL 4.0 (Pediatric Quality of Life 
Inventory)
Parent & Child Parent & Child
CFQ-R (Cystic Fibrosis Questionnaire – 
Revised)
Parent & Child Parent & Child
Ease of Breathing (Single breath counting 
score)
Pre & Post Pre & Post Pre & Post Pre & Post Pre & Post
Thoracic Excursion (Cloth Tape Measure)
Pre, During 
massage, Post
Pre, During 
massage, Post
Pre, During 
massage, Post
Pre, During 
massage, Post
Pre, During 
massage, Post
Numeric pain scale
(0 no pain;
10 worst possible pain)
Pre, during 
massage & Post
Pre, during 
massage & Post
Pre, during 
massage & Post
Pre, during 
massage & Post
Pre, during 
massage & Post
f/u phone call* f/u phone call* f/u phone call* f/u phone call* f/u phone call*
Numeric rating scale for muscle tightness 
(0-10 worst possible)
Pre & Post Pre & Post Pre & Post Pre & Post Pre & Post
f/u phone call* f/u phone call* f/u phone call* f/u phone call* f/u phone call*
Numeric rating scale for ease of breathing 
(0-10 worst possible)
Pre & Post Pre & Post Pre & Post Pre & Post Pre & Post
f/u phone call* f/u phone call* f/u phone call* f/u phone call* f/u phone call*
Numeric rating scale for relaxation 
(0-10 worst possible)
Pre & Post Pre & Post Pre & Post Pre & Post Pre & Post
f/u phone call* f/u phone call* f/u phone call* f/u phone call* f/u phone call*
Pulmonary Function Test (Forced Vital 
Capacity and Forced Expiratory Volume in 
1 minute)
Clinical Data 
Collected
X
* Phone calls (included call, text or email) were made 1-2 days following each study visit.
Summary of Treatment group schedule:
● Visit 1 was day 0. 
● Visit 2 was scheduled 5-10 days following visit 1. 
● Visit 3 was scheduled 12-17 days following visit 2. 
● Visit 4 was scheduled 19- 24 days following visit 3. 
● Visit 5 was scheduled 26-31 days following visit 4. 
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Control group visit schedule
Visit number: 1 Call Call Call 2
Study Week 0 1 3 6 10
Measures:      
Peds QL 4.0 (Pediatric Quality of Life 
Inventory) 
Parent & Child/
Teen or Young 
Adult
Parent & Child/
Teen or Young 
Adult
CFQ-R (Cystic Fibrosis Questionnaire – 
Revised)
Parent & Child Parent & Child
Ease of Breathing (Single breath counting 
score) 
X X
Thoracic Excursion (Cloth Tape Measure) X X
Numeric pain scale 
(0 no pain; 10 worst possible pain)
X
 f/u phone call*
f/u phone call f/u phone call f/u phone call
X
f/u phone call*
Numeric rating scale for muscle  
tightness (0-10 worst possible) 
X 
f/u phone call*
f/u phone call f/u phone call f/u phone call
X 
f/u phone call*
Numeric rating scale for ease of breathing  
(0-10 worst possible) 
X
f/u phone call*
f/u phone call f/u phone call f/u phone call
X 
f/u phone call*
Numeric rating scale for relaxation 
(0-10 worst possible)
X 
f/u phone call*
f/u phone call f/u phone call f/u phone call
X 
f/u phone call*
Pulmonary Function Test (Forced Vital  
Capacity and Forced Expiratory Volume in  
1 minute) 
Clinical Data 
collected
Clinical Data 
Collected
* Phone calls (included call, text or email) were made 1-2 days following each study visit and at study week 1, 3, and 6. 
Summary of control group schedule:
●  Visit 1 was day 0. 
●  Visit 2 was scheduled 10-12 weeks following visit 1.
Additionally, a study phone call, text or email was made at the following times:
●  1-2 days following visit 1. 
●  5-10 days following visit 1. 
●  19-24 days following visit 1. 
●  42-45 days following visit 1.
●  1-2 days following visit 2.
